Apologies... I really should refer to her as my late wife however I really hate the term because I'm far to young to have a late wife.
supertramp has summed up well what I was getting at: even if at worst B cell therapy is even with T cell therapy, B cell therapy will take over the market because quality of life is a major consideration to oncologists and it's highly unlikely they would prescribe their patients with drugs that cause side effects when side effect free drugs are available. I think B cell therapy will likely generate stronger and longer lasting responses which will make them superior on that front as well. B cell therapy has also been toted as being significantly cheaper which will be another consideration and will also open access to additional markets.
Whilst it's too late for my wife, I'm really excited and interested by what I'm seeing from IMU.
IMU Price at posting:
1.7¢ Sentiment: Buy Disclosure: Held
